Stress and inflammatory disease: Widening roles for serotonin and substance P

Stress

Volumn 4, Issue 1, 2001, Pages 57-70

  Harbuz, M S ^a   Jessop, D S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Arthritis; Corticosterone; CRF; HPA axis; Neurokinin receptors; Preprotachykinin

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; PREPROTACHYKININ; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; TACHYKININ RECEPTOR;

ADJUVANT ARTHRITIS; ARTHRITIS; CONFERENCE PAPER; DEPRESSION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SPLEEN; STRESS;

EID: 0034869120     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.3109/10253890109001143     Document Type: Conference Paper

References (96)

1. Functional diversity of helper T lymphocytes
2. Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test
3. Synovial fluid sampling from the temporomandibular joint: Sample quality criteria and levels of interleukin-1 beta and serotonin
4. Serotonin inhibition of tumor necrosis factor-alpha synthesis by human monocytes
5. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones
6. GR205171, a selective NK1 receptor antagonist attenuates stess-induced increase of dopamine metabolism in rat medial prefrontal cortex
7. Spinal mechanisms of acute and persistent pain
8. Adrenalectomy sensitizes mice to the lethal effects of interleukin I and tumor necrosis factor
9. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: Partial overlap with ascending catecholaminergic projections
10. Serotonin, stress and corticoids
11. Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat
12. Altered adrenocorticotropin, corticosterone and oxytocin responses to stress during chronic salt load
13. Endogenous substance P inhibits the expression of corticotropin-releasing hormone during a chronic inflammatory stress
14. Serotonin depletion does not alter lipopolysaccharide-induced activation of the rat paraventricular nucleus
15. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methyl-enedioxyamphetamine and fenfluramine on immunity in rats
16. Hypothalamic tachykinins: Mediators of stress responses?
17. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress
18. Fed, but not fasted, adrenalectomised rats survive the stress of hemorrhage and hypovolemia
19. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P
20. Brain corticosteroid receptor balance in health and disease
21. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function
22. Changes in plasma and brain tryptophan and brain serotonin and 5-hydroxyindoleacetic acid after footshock stress
23. Place aversion induced by the substance P analogue, dimethyl-C7, is not state dependent: Implication of substance P in aversion
24. Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro
25. Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion
26. Differential recovery of adrenocortical responses to neural stimuli following administration of 5,7-dihydroxytryptamine into the hypothalamus
27. The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?
28. Effect of intrathecal injection of pertussis toxin on substance P, norepinephrine and serotonin contents in various neural structures of arthritic rats
29. Serotoninergic and suprachiasmatic nucleus involvement in the corticotropic response to systemic endotoxin challenge in rats
30. Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides
31. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus
32. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation
33. Chronic inflammatory stress
34. Paradoxical responses of hypothalamic CRF mRNA and CRF-41 peptide and adenohypophyseal POMC mRNA during chronic inflammatory stress
35. Hypothalamo-pituitary responses to acute stress and changes in circulating glucocorticoids during chronic adjuvant-induced arthritis in the rat
36. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion
37. The role of endogenous serotonin in adjuvant-induced arthritis
38. The hypothalamic-pituitary-adrenal axis in autoimmunity
39. Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat
40. Differential effects of psychological and immunological challenge on the hypothalamo-pituitary-adrenal axis function in adjuvant-induced arthritis
41. Hypothalamo-pituitary-adrenal axis responses to lipopolysaccharide in male and female rats with adjuvant-induced arthritis
42. Sensitization to the effects of tumor necrosis factor-alpha: Neuroendocrine, central monoamine, and behavioral variations
43. NK1 (substance P) receptor antagonists - Why are they not analgesic in humans?
44. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress
45. Arthritis and serotonergic antidepressants
46. Specific uptake of serotonin by murine macrophages
47. Stimulatory and inhibitory regulators of the hypothalamo-pituitary-adrenocortical axis
48. Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis
49. Substance P is involved in terminating the hypothalamo-pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors
50. Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression
51. Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes
52. The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation
53. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
54. Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats
55. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat
56. Role of corticotropin-releasing factor and substance P in pressor responses of nuclei controlling emotion and stress
57. Regulation of murine T-lymphocyte function by spleen cell-derived and exogenous serotonin
58. Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat
59. Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus
60. Peptides and the primary afferent nociceptor
61. Local administration of recombinant human interleukin 1-beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature
62. Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: Involvement of the cyclo-oxygenase pathway
63. Effect of bacterial endotoxin and interleukin 1-beta on hippocampal serotonergic neurotransmission, behavioural activity and free corticosterone levels: An in vivo microdialysis study
64. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study
65. Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve
66. The role of the vagus nerve in cytokine-to-brain communication
67. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice
68. Neurokinin-1 receptors are involved in behavioral responses to high-intensity heat stimuli and capsaicin-induced hyperalgesia in mice
69. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues
70. Modifications of serotonin-, substance P- and calcitonin gene-related peptide-like immunoreactivities in the dorsal horn of the spinal cord of arthritic rats: A quantitative immunocytochemical study
71. Substance P in the median eminence and pituitary of the rat: Demonstration of immunoreactive fibers and specific binding sites
72. Th1/Th2 cytokine balance in arthritis
73. Lipopolysaccharide-induced changes in monoamines in specific areas of the brain: Blockade by interleukin-1 receptor antagonist
74. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6
75. Role of serotonin in the immune system and in neuroimmune interactions
76. Glucocorticoids and stress: Permissive and suppressive actions
77. A comparison of serotonin (5-HT) blood levels and activity of 5-HT2 antagonists in adjuvant arthritic Lewis and Wistar rats
78. The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation
79. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
80. Neurokinin B gene expression is increased in the arcuate nucleus of ovariectomized rats
81. A radioimmunoassay for rat plasma ACTH
82. Neural modulation of immune function
83. Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice
84. Discovery of the antidepressant and antiemetic efficacy of substance P receptor (NK1) antagonists
85. Substance P-evoked release of GABA from isolated spinal cord of the newborn rat
86. Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion
87. Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat
88. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat
89. Cytokine production by synovial T cells in rheumatoid arthritis
90. Receptor mediation of 5-HTinduced inflammation and nociception in rats
91. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses
92. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination
93. Changes in brain and spinal tryptophan and 5-hydroxyindoleacetic acid levels following acute morphine administration in normal and arthritic rats
94. Synergism between interleukin-6 and interleukin-1beta in hypothalamic serotonin release: A reverse in vivo microdialysis study in F344 rats
95. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin
96. Serotonin regulation of T-cell subpopulations and of macrophage accessory function